Fig. 6

Correlation of the ERSRPS with the immune landscape in osteosarcoma patients. A Violin plot showing the differences in the immune score, stromal score, estimate score, and tumor purity between the low- and high-risk groups. B, C Enrichment levels of immune-related cells and pathways between the low- and high-risk groups. D, E The proportion of patients responded to immunotherapy and ROC analysis between the low- and high-risk groups in the GSE35640 cohort and GSE78220 cohort. R, Response; NR, Non-response; *p < 0.05, **p < 0.01, ***p < 0.001